• 04 May, 2021

Some biopharma researchers are using artificial intelligence to identify unique brain signatures of Alzheimer’s disease, and to discover biomarkers in blood samples that can be used to personalize cancer treatments. Others are deploying gene-editing tools, advanced analytics and new imaging technologies to uncover new biomarkers that can improve the diagnosis and treatment of a range of diseases.
Read more...